Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress
Authors
Keywords
Liver fibrosis, CCl4, Meloxicam, NF-κB, Inflammation, Oxidative stress
Journal
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Volume 389, Issue 9, Pages 971-983
Publisher
Springer Nature
Online
2016-05-31
DOI
10.1007/s00210-016-1263-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice
- (2014) Memy H. Hassan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Modulator Effects of Meloxicam against Doxorubicin-Induced Nephrotoxicity in Mice
- (2014) Memy H. Hassan et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes
- (2014) Shi-Lei Wen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Sulfasalazine prevents the increase in TGF-β, COX-2, nuclear NFκB translocation and fibrosis in CCl4-induced liver cirrhosis in the rat
- (2012) E Chávez et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Meloxicam Modulates Oxidative Stress Status, Inhibits Prostaglandin E2, and Abrogates Apoptosis in Carbon Tetrachloride–Induced Rat Hepatic Injury
- (2012) Mohamed Edfawy et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Dietary Diacetylene Falcarindiol Induces Phase 2 Drug-Metabolizing Enzymes and Blocks Carbon Tetrachloride-Induced Hepatotoxicity in Mice through Suppression of Lipid Peroxidation
- (2011) Tomokazu Ohnuma et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Evolution of hepatic fibrosis research
- (2011) Norifumi Kawada HEPATOLOGY RESEARCH
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
- (2011) Tom Luedde et al. Nature Reviews Gastroenterology & Hepatology
- Insights antifibrotic mechanism of methyl palmitate: Impact on nuclear factor kappa B and proinflammatory cytokines
- (2011) Eman M. Mantawy et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Antifibrotic effects of chronic baicalein administration in a CCl4 liver fibrosis model in rats
- (2010) Hong Sun et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Protective Effects of Vitamin E Analogs against Carbon Tetrachloride-Induced Fatty Liver in Rats
- (2010) Rieko Yachi et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice
- (2010) George L. Tipoe et al. TOXICOLOGY
- N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress
- (2009) Marina Galicia-Moreno et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Effect of selective cyclooxygenase-2 inhibitor meloxicam on liver fibrosis in rats with ligated common bile ducts
- (2008) Seong Min Kim et al. HEPATOLOGY RESEARCH
- Hepatoprotective Effect of Infliximab, an Anti-TNF-α Agent, on Carbon Tetrachloride-Induced Hepatic Fibrosis
- (2008) Ibrahim Halil Bahcecioglu et al. INFLAMMATION
- Methyl palmitate prevents CCl4-induced liver fibrosis
- (2008) Adriana Rodríguez-Rivera et al. JOURNAL OF APPLIED TOXICOLOGY
- Beneficial drugs for liver diseases
- (2007) Pablo Muriel et al. JOURNAL OF APPLIED TOXICOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started